Back to Search
Start Over
Subcutaneous defibrillators for dialysis patients
- Source :
- Hemodialysis International. 22:4-8
- Publication Year :
- 2017
- Publisher :
- Wiley, 2017.
-
Abstract
- Defibrillation can be successfully provided by the subcutaneous implantable cardioverter defibrillator (ICD) without the leads. In contrast, traditional ICDs require leads that can cause central venous stenosis, lead-induced endocarditis, and carry the risk of tricuspid regurgitation by valve adhesion, perforation, coaptation interference, or entanglement. Central venous stenosis, infection, and tricuspid regurgitation are all critically important considerations in hemodialysis patients. Recent reports are supporting the use of subcutaneous ICDs in renal patients maintained on long-term hemodialysis. This article provides the risks associated with leads of traditional defibrillators and raises awareness of the subcutaneous ICD and their benefits for hemodialysis patients.
- Subjects :
- medicine.medical_specialty
business.industry
Defibrillation
medicine.medical_treatment
Perforation (oil well)
030232 urology & nephrology
Hematology
Dialysis catheter
Regurgitation (circulation)
030204 cardiovascular system & hematology
Dialysis patients
Implantable cardioverter-defibrillator
medicine.disease
Surgery
03 medical and health sciences
0302 clinical medicine
Nephrology
Internal medicine
medicine
Cardiology
Endocarditis
Hemodialysis
business
Subjects
Details
- ISSN :
- 14927535
- Volume :
- 22
- Database :
- OpenAIRE
- Journal :
- Hemodialysis International
- Accession number :
- edsair.doi...........e172b32cbb433b8c590063cf7255ca26
- Full Text :
- https://doi.org/10.1111/hdi.12577